While there was nosignificant association between efficacy for DVT resolution and Hb level, FPX 7.5 mg wasstarted on postoperative day 3 in all three patients whose Hb decreased to ≤7 g/dL. This evidence concerns the gene GSTM1 and deep vein thrombosis.